Supplementary Figures from Monitoring Circulating Tumor DNA During Surgical Treatment in Patients with Gastrointestinal Stromal Tumors

Supplementary Figure S1 shows assessment of quality controls when analyzing cfDNA. Supplementary Figure S2 shows a representative electropherogram of assay performance Supplementary Figure S3 shows a the amount of cfDNA in plasma for different risk groups and sample types.